Riskpilot← Back to searchSign inGet full accessRoshine vård och utbildning AB
ABActiveOrg 5592391428Other human health activities n.e.c. · NACE 8699Est. 20200 employees
Revenue 2025
SEK 0
EBITDA margin
—
+21% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -13K
+21% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | +21% |
| Net profit | SEK -13K | +21% |
| Total assets | SEK 553K | -2% |
| Equity | SEK 553K | -2% |
| Employees | 0 | — |
Legal name
Roshine vård och utbildning AB
Org number
5592391428
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
28 januari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva konsultverksamhet med fokus på ledarskap, personalledning, organisationsutveckling, utbildning inom såväl privat som offentlig sektor. Bolaget ska också bedriva utbildningsverksamhet, genomföra föreläsningar och därmed förenlig verksamhet. Vidare ska bolaget bedriva investeringsverksamhet och äga andelar i andra företag.
Address
Email
info@winwin-ekonomi.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 120 | 138 | 69 | −0 | 0 |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | 63 | 73 | 85 | −16 | −13 |
| Depreciation & amort. | −61 | −61 | −10 | — | — |
| EBIT | 2 | 12 | 75 | −16 | −13 |
| Net financials | −12 | −11 | 748 | 0 | 0 |
| Profit before tax | −10 | 0 | 823 | −16 | −13 |
| Tax | −0 | — | −16 | — | — |
| Net profit | −10 | 0 | 807 | −16 | −13 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 553 | 539 | 888 | 566 | 553 |
| Equity | 62 | 62 | 869 | 566 | 553 |
| Long-term debt | 465 | 435 | 0 | — | — |
| Short-term debt | 26 | 42 | 19 | 0 | −0 |
| Total debt | 491 | 476 | 19 | — | −0 |
EBITDA margin
-1270300.0%
This company
15.8%
Market median
-8039973% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
-2.3%
This company
18.4%
Market median
-113% vs market
20212025
Net profit margin
-1254500.0%
This company
8.1%
Market median
-15487754% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
-0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Roshine vård och utbildning AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mehrdad Tayeban-Hamedani | Board of Directors | 0 companies |
| Sharareh Haghnabi | Deputy Board Member | 0 companies |